Compounds > ezetimibe
Page last updated: 2024-09-04

ezetimibe and Osteoporosis, Postmenopausal

ezetimibe has been researched along with Osteoporosis, Postmenopausal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vervaeren, J1
Böcking, W; Bramlage, P; Kirch, W; Mueller, EA1

Reviews

1 review(s) available for ezetimibe and Osteoporosis, Postmenopausal

ArticleYear
[Innovation instead of imitation -- news in drug therapy].
    Deutsche medizinische Wochenschrift (1946), 2005, Apr-01, Volume: 130, Issue:13

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Anticoagulants; Antineoplastic Agents; Azetidines; Body Weight; Cannabinoid Receptor Antagonists; Cetuximab; Drug Therapy; Ezetimibe; Fondaparinux; Humans; Hypoglycemic Agents; Insulin; Osteoporosis, Postmenopausal; Piperidines; Polysaccharides; Pyrazoles; Rimonabant; Smoking Cessation; Teriparatide; Thromboembolism

2005

Other Studies

1 other study(ies) available for ezetimibe and Osteoporosis, Postmenopausal

ArticleYear
[Some new drugs: valdecoxib (Betra), voriconazole (Vfend), ezetimide (Ezetrol), teriparatide (Forsteo)].
    Journal de pharmacie de Belgique, 2004, Volume: 59, Issue:3

    Topics: Antifungal Agents; Azetidines; Cyclooxygenase Inhibitors; Ezetimibe; Female; Humans; Hypolipidemic Agents; Isoxazoles; Osteoporosis, Postmenopausal; Pyrimidines; Sulfonamides; Teriparatide; Triazoles; Voriconazole

2004